Home Portfolio Clinical Trials
Clinical Trials
CID-103
Multiple Myeloma (MM)
Jun 2021   EU
Dosing of first patient in Phase I clinical trial
Jun 2024   CN
CTA approval
Immune Thrombocytopenia (ITP)
May 2024   US
CTA approval
Aug 2024   CN
Join international multi-center CTA
Antibody-Mediated Rejection in Renal Transplantation (AMR)
Q4 2024   CN-US
Submission of international multi-center CTA
BI-1206
Indolent B-cell Non-Hodgkin’s Lymphoma(iNHL)
Jan 2022   US
Orphan drug designation for follicular lymphoma
Sep 2022   CN
Dosing of first patient in Phase I clinical trial
Solid Tumors
Jun 2020   INT
Recruitment for the clinical trial
CB-5339
Multiple Myeloma(MM)
May 2023   CN
CTA approval
Acute Myeloid Leukemia(AML)
May 2020   INT
CTA approval
Myelodysplastic Syndromes(MDS)
May 2020   INT
CTA approval